Fundraisings and IPOs

Date: 2018-01-04

Type of information: Loan

Company: Enterome Bioscience (France)

Investors: European Investment Bank (EIB)

Amount: €40 million

Funding type: loan

Planned used:


  • • On January 4, 2018, Enterome announced that in conjunction with its equity financing, the company has entered into an agreement with the European Investment Bank (EIB) for access to a €40 million loan facility to further support the acceleration of its pipeline and technology development.

Therapeutic area: Liver diseases - Hepatic diseases - Inflammatory diseases - Digestive diseases - Cancer - Oncology

Is general: Yes